About Conference

    Dear Colleagues,

    Apex Global Meetings is delighted to announce and cordially invites all the participants across the globe to attend “Global Summit on Neurology and Neurological Disorders’’(Neuro2024) which will be taking place during August 22-24, 2024 at  Kuala Lumpur, Malaysia. The theme of the conference highlights Neuroscience Revealed: Decoding the Mysteries of the Brain’’ Scientific Tracks designed for this conference will enable the attendees and participants to learn extremes.

    Neuro2024 aims to gather the renowned scientists, young and brilliant researchers, academicians, experts, healthcare professionals, business delegates, and exceptional student communities across the globe under one roof and organize a healthy discussion so that the researchers and authors can present their work at the conference. Neuro2024 objective is to provide a comprehensive global forum for experts and participants from academia to exchange ideas and present results of on-going research in the most state-of-the-art areas of Neurology and neurological disorders and allied topics. It will be hosting a forum of plenary, keynote, Invited lectures and oral/ poster presentations.

    We accept this gathering will be an exceptionally remunerating instructive and collaborative occasion for the attendees.

    We look forward to your valuable presence at Neuro2024 in Kuala Lumpur, Malaysia.

    Poojitha A | Event Manager
    Apex Global Meetings
    Email: secretary@neurosummit2024.com




    Alzheimer Disease & Parkinson Disease

    Clinical Neurology


    Neuroradiology and imaging evaluations


    Neuroscience & Neuro surgery



    Pain Management & Sleep Disorders

    Stroke / Cerebro Vascular Diseases

    sensory processing

    Traumatic brain injury

    Neuro Endocrinology

    Neuro-degenerative Diseases


    Multiple Sclerosis

    Epilepsy & Depression


    Behavioral neuroscience & Mental health

    Cognitive neuroscience


    Brain Cancer



    Unlocking Insights into a Rapidly Evolving Healthcare Segment


    Welcome to our in-depth market analysis of the neurology and neurological disorders field, a vital sector at the intersection of medicine, science, and patient care. In this exploration, we delve into the key aspects driving this market's growth, the major neurological disorders of concern, innovative treatment approaches, challenges faced, and a glimpse into the future landscape.


    Understanding the Neurology Landscape


    Neurology, a specialized branch of medicine, is dedicated to diagnosing, treating, and managing disorders impacting the nervous system. From the intricate circuitry of the brain to the sprawling network of peripheral nerves, neurology covers an array of conditions ranging from common migraines to complex disorders like Alzheimer's and Parkinson's disease.


    Market Size and Growth Factors


    The global neurology and neurological disorders market is experiencing remarkable expansion owing to several key factors:


    Aging Population: As our global population ages, neurological disorders such as Alzheimer's and Parkinson's become more prevalent, creating a demand for advanced treatments and management strategies.


    Technological Advancements: Innovations in neuroimaging, genetics, and molecular biology are enhancing our understanding of these disorders, leading to targeted therapies and personalized treatment options.


    Heightened Awareness: Increased public awareness of neurological disorders and their symptoms is promoting early diagnosis and intervention.


    Investment in Research: Pharmaceutical and biotechnology companies, along with research institutions, are investing significantly in developing innovative treatments for neurological disorders. This includes both treatments that modify the course of the disease and those that manage symptoms effectively.


    Emerging Markets: Growing healthcare infrastructure in developing markets is widening access to neurological care and treatments, contributing to overall market growth.


    Major Neurological Disorders


    We turn our attention to some of the most prevalent neurological disorders:


    Alzheimer's disease: A leading cause of dementia, the global market for Alzheimer's disease was valued at around $7 billion in 2020, and this figure is projected to rise with increasing disease prevalence.


    Parkinson's disease: Affecting movement and commonly seen in the elderly, the Parkinson's disease market reached a value of over $3 billion in 2020.


    Multiple Sclerosis: This autoimmune disorder of the central nervous system had a market valuation of approximately $22 billion in 2020.


    Epilepsy: Characterized by recurring seizures, the epilepsy therapeutics market was valued at about $4 billion in 2020.


    Migraine: The migraine therapeutics market, addressing this common neurological disorder causing severe headaches, was valued at over $3 billion in 2020.


    Approaches to Treatment


    In the realm of treatment, the following approaches take center stage:


    Pharmaceuticals: Intensive research focuses on developing disease-modifying therapies and symptom management strategies, encompassing biologics, small molecules, and ground-breaking gene therapies.


    Medical Devices: Specialized medical devices, such as deep brain stimulation implants for Parkinson's or neurostimulator devices for epilepsy, play a crucial role in managing neurological disorders.


    Therapies and Rehabilitation: Neurological disorder management often requires comprehensive therapies like physical, occupational, and speech therapy, aiding patients' overall well-being.


    Navigating Challenges


    While the prospects are promising, the neurology and neurological disorders market is not without its challenges:


    Research Costs: The intricate nature of the nervous system and the need for rigorous clinical trials contribute to the high costs of researching new treatments.


    Regulatory Hurdles: The unique characteristics of each disorder and the necessity for long-term safety data can pose challenges in gaining regulatory approvals.


    Limited Efficacy: A lack of effective disease-modifying treatments for many neurological disorders places a strong emphasis on symptom management and patients' quality of life.

    Equitable Access: Disparities in healthcare access and resources can impact the diagnosis and treatment of neurological disorders, particularly in less affluent regions.

    Future Horizons

     The future of the neurology and neurological disorders market shines bright.


    Important Dates

    Abstract Submission Deadline

    May 25, 2024

    Earlybird Registration Deadline

    April 15, 2024

    Standard Registration Deadline

    July 15, 2024

    Onspot Registration

    August 22, 2024

    Our Exhibitors/Collaborators

    Scientific Committee

    Volen Atim

    Dr. Jean Marc Sabatier

    Aix Marseille University
    Volen Atim

    Prof. Michel Bourin

    University of Nantes
    Volen Atim

    Assoc. Prof. Yiannis Koumpouros

    University of West Attica
    Volen Atim

    Dr. Kalliopi Megari

    Aristotle University of Thrace

    Plenary Speakers

    Dr. Abdulrazaq S. Albilali

    KSU Neurologist and Headache Specialist
    Saudi Arabia

    Dr. Nicolas G. Bazan

    Neuroscience Center of Excellence Louisiana State University Health New Orleans

    Dr. David Wortley

    Bournemouth University

    Prof. W S El Masri

    Keele University
    United Kingdom

    Prof. Christoph Helmstaedter

    H-index 90
    University of Bonn

    Prof. Hermona Soreq

    H-index 97
    The Hebrew University of Jerusalem

    Prof. Fadel Tissir

    University of Louvain

    Prof. Guo Yi

    Jinan University

    Keynote Speakers

    Dr. Roberto De Luca

    Beth Israel Deaconess Medical Center

    Dr. Peter Karachunski

    University of Minnesota

    Dr. Yazeed Alzahrani

    Prince Sattam bin Abdulaziz University
    Saudi Arabia

    Prof. Elka Stefanova

    University of Belgrade

    Dr. Fabio Alex Fonseca Viegas

    University of Cuiaba

    Dr. Mohamed Fawzy

    Al-Azhar University

    Dr. Alan Wang

    University of Auckland
    New Zealand

    Assoc. Prof. Tuan Tran

    Thai Nguyen University of Medicine and Pharmacy

    Dr. Ivana Cajic

    University of Split

    Invited Speakers

    Dr. Khamsehashari Razieh

    Technische University Berlin

    Dr. Marilyn Zaldivar Bermudez

    Ciren International Center for Neurological Restoration
    Havana Cuba

    Dr. Payam Seydo

    Alfaisal University
    Saudi Arabia

    Dr. Jitendra Vishwakarma

    CSIR-Indian Institute of Toxicology Research

    Dr. Michelle Beukes King

    President Pain SA
    South Africa

    Dr. Solomon Omaido

    Liberty University Online Programs

    Media Partners


    Registration Includes

    • Access to all conference sessions, poster and exhibition area
    • Conference kit including name tag, program booklet and Abstracts book
    • 2 Coffee breaks and lunch for all the event days of the conference
    • Certificate of participation from Conference chair/ Session chair
    • Access to the all scientific sessions
    • Access to Business Development Sessions and Global Networking Session

    Benefits of Joining Conference

    • Encouraged to publish full length articles in Supporting Journals with discounted APC charges
    • Best Oral, Poster and Young Research Forum (YRF) presentation awards
    • Get Opportunity to Collaborate with future Apex Global Meetings
    • Avail Group Booking Discounts
    • All the articles presented in this conference will be considered for publications as per their quality in SCI / SCIE / SCOPUS / Peer Reviewed journals of Springer and / or other publishers

    Group Booking Discounts

    Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call